Key Takeaways:
- Our experts provide assistance and guidance on PFAS, addressing regulatory liabilities and exposure-related challenges, which can inform strategies for complying with OSHA’s Hazard Communication Standard (29 CFR 1910.1200) regarding PFAS in the workplace.
- RHP offers health and safety audits for manufacturers or users of PFAS, including Safety Data Sheet evaluations, to help businesses identify and manage potential hazards and ensure compliance with OSHA’s requirements for chemical safety in the workplace.
- We provide human health risk assessments and risk communication tailored to individual audiences, which can be used to develop appropriate control measures and training programs to protect workers from PFAS exposure, aligning with OSHA’s emphasis on hazard prevention and worker education.
PFAS are a complex group of synthetic chemicals consisting of carbon-fluorine bonds which are used across industries and in primary and secondary consumer products due to their thermal and chemical stability and water and stain resistance.
With the regulatory liabilities, exposure-related challenges, toxicology complexities, and expansive epidemiological literature surrounding PFAS, both nationally and internationally, RHP Risk Management experts can provide assistance and guidance with this family of chemicals through:
- Regulatory Assistance
- Compliance for use and waste
- Interpretation of proposed rules and submission of comments
- Health and Safety Audits for manufacturers or users
- Safety Data Sheet evaluation
- Historic waste processes and secondary use
- Product Support
- Labeling throughout product lifestyle from origin to use and distribution
- Formula reviews of products
- Human Health Risk Assessment
- Development of Hazard Summaries
- Exposure Modeling and Monitoring
- Risk Evaluation
- Consult on appropriate use of toxicological data, including pharmacokinetic considerations
- Advise on epidemiological evidence causality vs. association
- State of Science
- Risk communication tailored to individual audiences
graphic courtesy EPA – (click to enlarge)
RHP experts continue to follow and provide guidance in addressing regulatory updates including:
- Toxic Substances Control Act (TSCA) Reporting and Recordkeeping Requirements for PFAS.
- EPA PFAS National Primary Drinking Water Regulation and recent updates.
- FDA Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Additionally, RHP scientists have joined the efforts of an international team of researchers, regulators, industry, and academia in performing human health risk assessment evaluations on a variety of PFAS compounds.
The first compound assessed was PFOA, see Dr. Frank Pagone’s publication reporting on a safe dose range. Follow RHP’s Drs. Frank Pagone and Ashish Jachak and this acclaimed team, the Alliance for Risk Assessment (ARA), as they tackle the compound PFOS.